Friday, October 5, 2018 - 11:00 a.m. - 4:00 p.m.
Joint Session - AOAAM and AMOPS
The intent of the Joint AOAAM / AMOPS session "Veterans and Trauma / Pain / TBI / Substance Use and Recovery" is to increase awareness and strengthen interdisciplinary teams in trauma rehabilitation.
Saturday, October 6, 2018 - 8:00 a.m. - 5:00 p.m.
AOAAM's Essentials of Addiction Medicine Course
This program is designed to provide up-to-date data and practice techniques for basic through advanced addiction treatment.
Sunday, October 7, 2018 - 8:00 a.m. - 4:30 p.m.
8:00 a.m. - 9:20 a.m.
Health Disparities in Substance Use Disorders
This session will cover the history of the addiction epidemic and the current treatments available as well as the need for prevention. It will also discuss the disparities that affect access to SUD treatment. Federal policies and laws that support or inhibit treatment will also be touched on.
9:20 a.m. - 10:20 a.m.
Osteopathic Physicians as Leaders in Addiction Medicine: Opportunities and Barriers
Substance Use Disorders (SUD) provide the underlying diagnoses for the majority of morbidity, mortality, social disruption and public health deficits in America. SUD and addiction are complex diseases, often chronic, modulated by genetics, neurobiology and the environment. They are amenable to evidence informed prevention and treatment. American medicine has failed at containing their destruction, which is in fact now accelerating. Osteopathic medicine and osteopathic physicians can bring a new and desperately needed set of values, attitudes and approaches to bear on our national endemic and epidemic drug problems.
10:30 a.m. - 12:00 p.m.
LGBTQ and Addiction Medicine
This lecture will help physicians recognize patients in the LBGTQ community with SUD. It will give them the tools and resources to communicate and better assist the individuals who are a part of the LBGTQ community.
1:30 p.m. - 4:30 p.m.
What the Heck, it’s Just Marijuana
Accidental overdose on opiates is now the leading cause of accidental death in the U.S. In America, we comprise 25% of the world's population and consume 99% of the world's hydrocodone. As far back as 1889, doctors have been exploring the use of cannabis for opiate dependence. A sharp increase in opiate fatalities coupled with the population most impacted has regulators, researchers and others looking for novel approaches, including cannabis. This session will focus on three points at which cannabis can interface with opiates to encourage harm reduction: as a first line defense for pain, as a withdrawal medication, and as a maintenance medication to prevent relapse. Research in the area of cannabis and harm reduction will be presented, as well as perspectives from Addiction Medicine experts and patent(s).
Monday, October 8, 2018 - 8:00 a.m. -5:00 p.m.
Advanced Addiction Medicine Course - NEW 2018
The Advanced Program in Addiction Medicine will include hot topics affecting seasoned addiction medicine physicians. Those who have completed the Essentials Program are urged to attend this course.
Tuesday, October 9, 2018 - 7:30 a.m. - 4:30 p.m.
8-hour Buprenorphine Waiver Training
Medication Assisted Treatment (MAT) of Substance Use Disorders involves a combination of a medication that targets the brain, and psychosocial interventions aimed at improving treatment outcomes. Research shows that medications and therapy together may be more successful than either treatment method alone. PCSS-MAT intends to provide free, evidence-based resources to train clinicians and the public about the effectiveness of medications used for treating opioid addiction, including buprenorphine, naltrexone and methadone, to more effectively address this public health crisis.